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AbstrAct
The ventilator-associated event (VAE) is a potentially 
avoidable complication of mechanical ventilation (MV) 
associated with poor outcomes. Although rare, VAEs 
and other nosocomial events are frequently targeted for 
quality improvement efforts consistent with the creed to 
‘do no harm’. In October 2016, VA Greater Los Angeles 
(GLA) was in the lowest-performing decile of VA medical 
centres on a composite measure of quality, owing to GLA’s 
relatively high VAE rate. To decrease VAEs, we sought 
to reduce average MV duration of patients with acute 
respiratory failure to less than 3 days by 1 July 2017. In 
our first intervention (period 1), intensive care unit (ICU) 
attending physicians trained residents to use an existing 
ventilator bundle order set; in our second intervention 
(period 2), we updated the order set to streamline order 
entry and incorporate new nurse-driven and respiratory 
therapist (RT)-driven spontaneous awakening trial (SAT) 
and spontaneous breathing trial (SBT) protocols. In period 
1, the proportion of eligible patients with SAT and SBT 
orders increased from 29.9% and 51.2% to 67.4% and 
72.6%, respectively, with sustained improvements through 
December 2017. Mean MV duration decreased from 7.2 
days at baseline to 5.5 days in period 1 and 4.7 days in 
period 2; statistical process control charts revealed no 
significant differences, but the difference between baseline 
and period 2 MV duration was statistically significant 
at p=0.049. Bedside audits showed RTs consistently 
performed indicated SBTs, but there were missed 
opportunities for SATs due to ICU staff concerns about 
the SAT protocol. The rarity of VAEs, small population of 
ventilated patients and infrequent use of sedative infusions 
at GLA may have decreased the opportunity to achieve 
staff acceptance and use of the SAT protocol. Quality 
improvement teams should consider frequency of targeted 
outcomes when planning interventions; rare events pose 
challenges in implementation and evaluation of change.
Problem
The U.S. Centers for Disease Control and 
Prevention (CDC) has stated that eliminating 
healthcare-associated infections (HAIs) is a 
‘Winnable Battle’ because interventions exist 
to mitigate public health impact.1 Surveil-
lance for one type of HAI, ventilator-associ-
ated pneumonia (VAP), was challenging due 
to the absence of a consistent, objective defi-
nition for VAP, so in 2013, the CDC launched 
a new case definition using readily obtainable 
data: the ventilator-associated event (VAE). 
VAEs are sustained increases in oxygenation 
needs of a patient on mechanical ventila-
tion (MV) following a period of stability or 
improvement and have been associated with 
longer intensive care unit (ICU) and hospital 
lengths of stay and higher mortality.2–4 VAEs 
may not be completely preventable, although 
decreasing MV exposure with ventilator 
weaning practices is recommended.5 Patients 
must be ventilated for at least four calendar 
days to fulfil VAE criteria.6
The U.S. Department of Veterans Affairs 
(VA) assesses performance at VA medical 
centres using a scorecard of measures called 
Strategic Analytics for Improvement and 
Learning (SAIL); it includes VAEs with 
other HAIs in the ‘avoidable adverse events’ 
domain of its quarterly reports.7 In October 
2016, VA Greater Los Angeles (GLA) ranked 
in the bottom decile of all VA medical centres 
in overall SAIL performance, and GLA lead-
ership selected HAIs as one of six targets for 
improvement. We focused on VAEs since 
their incidence (6.8 events per 1000 venti-
lator days in the 18 months preceding our 
intervention) was worst of all HAI measures 
based on the VAE benchmark of zero events 
in all VA medical centres nationally.7
At the time of our project, all MV patients 
at GLA were admitted to a 22-bed combined 
medical/surgical ICU where they received 
care from multidisciplinary teams consisting 
of physicians, nurses and respiratory thera-
pists (RTs), among others. Coordinating these 
providers for ventilator weaning was difficult 
because of frequent resident and nurse turn-
over and limited RT availability. GLA is affili-
ated with several residency programmes from 
nearby universities, so residents may have 
spent only 4 weeks at GLA over an academic 
year. Although nurses’ presence was more 
stable relative to residents, GLA experienced 
high nursing staff turnover and hired a new 
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ICU nurse manager in September 2016. RTs caring for 
MV patients had simultaneous assignments in other 
non-ICU areas of the hospital but were available by pager.
Non-personnel factors also affected ventilator processes. 
The ICU case severity index, a measure of illness severity 
with higher indices reflecting a higher proportion of 
more critically ill patients, was higher at GLA than other 
VA medical centres in southern California. Conversely, 
the ventilator utilisation ratio (ie, ventilator days divided 
by ICU bed days) of 0.27 was below the nationwide VA 
system average (0.34, 0.25 and 0.18 were the 50th, 25th 
and 10th percentiles, respectively, based on the latest avail-
able national data from 2014)8 and half of MV patients on 
average had sedative infusion orders. While having and 
sedating fewer MV patients may decrease VAE risk at the 
unit level, these practices reduce opportunities to stan-
dardise ventilator weaning for individual MV patients.
Our specific aim was to decrease average MV duration 
of patients with acute respiratory failure (ARF) to less 
than 3 days (from a baseline of 7.2 days) by 1 July 2017.
background
Evidence for VAE prevention comes mostly from observa-
tional studies. In their 2014 guideline update, the Infec-
tious Diseases Society of America (IDSA) and Society for 
Healthcare Epidemiology of America (SHEA) recom-
mended adopting VAP prevention strategies to also 
prevent VAEs, including daily sedation interruptions in 
spontaneous awakening trials (SATs) and daily assess-
ments of extubation readiness in spontaneous breathing 
trials (SBTs) to decrease MV duration.5 Because acute 
respiratory distress syndrome, fluid overload and haem-
orrhage can cause VAEs, some experts suggest low tidal 
volume ventilation, conservative fluid management and 
conservative transfusion thresholds as additional preven-
tion strategies.3 9 One retrospective cohort study in 2015 
found significant associations between SATs, SBTs, head 
of bed elevation, thromboembolism prophylaxis and 
chlorhexidine oral care with shorter time to extubation 
and lower on-ventilator mortality, but only SBTs were 
associated with decreased VAE likelihood.10
Although IDSA/SHEA guidelines suggest bundling 
interventions to improve compliance with these prac-
tices,5 literature on implementing ventilator bundles 
is mixed.11–15 Improvement teams in two Scottish ICUs 
reduced VAP rates in both hospitals using different strat-
egies; one changed workflows to close communication 
gaps between providers, while the other used key opinion 
leaders and huddles to reinforce desired behaviours.16 
In 2007, a systematic review of VAP prevention studies 
showed decreased VAP rates in several ICUs in the USA, 
Argentina and Pakistan through implementation of 
similar educational programmes combined with surveil-
lance feedback.17 In these studies, however, baseline VAP 
rates were fairly high, ranging from 7.5 to 51.3 infections 
per 1000 ventilator days. A cluster-randomised trial of 60 
ICUs in the USA (with median baseline VAP rate of 2.9 
infections per 1000 ventilator days) compared a toolkit 
with a virtual collaborative implementation strategy to 
reduce VAP. Although ICUs in the virtual collaborative 
group implemented ventilator bundles more often, there 
was no difference in VAP rates between the groups after 
18 months.18 The gap between guidelines and effective 
implementation strategies is widely recognised.13 16 19 
Nonetheless, in our case, the imperative for improvement 
was strong enough to proceed with guideline-concordant 
strategies.
measuremenT
Our overall goal was to reduce VAE incidence (ie, 
number of VAEs divided by ventilator days); however, 
due to the relative rarity of VAEs, using VAE incidence as 
our primary measure of improvement was not ideal. We 
instead used MV duration as a proxy. Based on studies 
that used MV duration as an outcome, average MV dura-
tion ranges from 1.5 to 7.9 days.20–24 Our goal MV dura-
tion of less than 3 days was based on the VAE definition 
since no optimal threshold exists. Patients who meet this 
goal effectively can only improve the VAE incidence by 
contributing solely to the denominator; by definition, 
VAEs occur only in patients intubated for at least four 
calendar days. However, our objective of reducing MV 
duration was primarily motivated by the intent to reduce 
HAIs by minimising exposure to devices (ie, central lines, 
indwelling urinary catheters and ventilators).
We defined our primary outcome, MV duration, as the 
number of calendar days from intubation to extubation. 
If a patient was intubated on the evening of 1 January and 
extubated on the morning of 2 January, we counted this 
as two calendar days. Reintubations were treated as sepa-
rate episodes; if a patient was intubated from 1 January to 
3 January and had to be reintubated from 11 January to 
13 January, we counted this as two occurrences of three 
calendar days of MV. We aggregated data as monthly aver-
ages on a run chart and as quarterly averages on an XbarS 
chart; the run chart allowed us to more quickly iden-
tify special cause variation signals and the XbarS chart 
allowed us to smooth month-to-month variation. Theo-
retically, it is possible to have the same average MV dura-
tion in two different months, with 1 month having greater 
overall VAE risk (eg, with 100 patients each intubated 
for 4 days) and the other month having lower overall 
VAE risk (eg, with a single patient intubated for 4 days), 
implying that MV duration is not a direct proxy for VAE 
risk. We accepted this shortcoming since our interven-
tions mitigated patient-level rather than unit-level VAE 
risk. Number of calendar days between VAEs was plotted 
on a t chart as a secondary outcome. Balancing measures 
included the monthly number of MV patients (to capture 
reintubations), ICU case severity index and ventilator 
utilisation ratio, which we plotted on XmR charts and a 
p chart.
For our process measures, we chose proportions 
of SAT-eligible and SBT-eligible patients with the 
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corresponding order for SAT or SBT present. To be 
eligible for an SAT order, a patient needed a sedative infu-
sion (eg, midazolam, lorazepam, propofol and dexme-
detomidine) ordered for at least 24 hours; to be eligible 
for an SBT order, a patient needed to be on MV for at 
least two calendar days. Orders were considered present 
if entered during the MV episode. We aggregated process 
measure data monthly on p charts.
We obtained data from monthly retrospective chart 
reviews of MV patients and grouped measurements into 
three periods: baseline (May 2015 to October 2016), 
period 1 (following our first intervention, November 
2016 to March 2017) and period 2 (following our second 
intervention, April 2017 to December 2017). We used QI 
Macros 2017 to build and analyse our charts; for all charts, 
we ‘froze’ the central line (ie, median for run chart and 
mean for statistical process control charts) from the base-
line period to more accurately detect special cause varia-
tion signals according to the Westgard rules and treated 
periods 1 and 2 together as the intervention period.25 26 
We supplemented our chart analysis with classical para-
metric statistics using STATA/IC V.14.2. We excluded 
patients recovering postoperatively from anaesthesia or 
with long-term ventilator dependence (ie, did not have 
ARF) as they are not generally sedated or placed on SBTs 
for ventilator weaning.
design
The GLA Institutional Review Board determined this 
project to be quality improvement, non-research activity.
Our improvement team convened in October 2016 
and included the medical and surgical ICU directors, 
chief medical/surgical nurse, ICU nurse manager, RT 
director, inpatient pharmacy manager, infection control 
staff, workgroup chairs and quality improvement fellow 
(author MMC). We first reviewed charts for all nine 
patients who had VAEs in 2016 to identify systemic issues. 
Documentation of worsening oxygenation in progress 
notes was sparse and, when present, insufficient to infer 
root causes. Most VAEs occurred in medical ICU patients, 
and all but one patient was intubated for more than 7 days 
before the VAE occurred. Because we did not discover 
a root cause from this investigation, we proceeded to 
determine our compliance with consensus guidelines 
described previously.
Nearly a decade before beginning this project, the 
medical ICU director and Critical Care Committee 
designed a ventilator bundle order set in our electronic 
medical record (EMR) that grouped IDSA/SHEA-recom-
mended VAP prevention strategies (ie, SAT, SBT, head of 
bed elevation, chlorhexidine oral care, and stress ulcer 
and thromboembolism prophylaxis) with medication 
orders commonly used for intubated patients (ie, seda-
tion and analgesia drips, as-needed delirium medications 
and enteral nutrition orders). A spot check of MV patients 
in October 2016 showed order set underutilisation. 
Insufficient education and lack of emphasis on bundle 
compliance explained this finding; residents rotate 
through the ICU for short periods with brief orientations. 
Furthermore, we found the order set cumbersome to use; 
ventilator settings were featured at the end of the order 
set with the intention to oblige residents to order nine 
other ventilator care elements, including ones with less 
evidence or duplicates from other order sets. Technical 
limitations in our EMR when the order set was originally 
coded also disrupted the order set’s flow.
Our first intervention (period 1) was to address the 
residents’ knowledge gap. The medical and surgical ICU 
directors requested their attending physicians, when 
on service, to train residents on using the order set to 
improve bundle compliance. We expected this interven-
tion to change the residents’ behaviours and improve 
bundle use through education and also by expecta-
tion-setting and influence of authority. To address the 
order set’s usability, we simultaneously began revising its 
content and layout for our second intervention (period 
2); we sought to create a convenient and streamlined 
‘one-stop shop’ that would suit the needs of a heteroge-
neous group of residents.
sTraTegy
We implemented the educational directive of period 1 in 
November 2016. Because SATs and SBTs were intermit-
tently performed during daily rounds, attending physi-
cians had been unaware that ventilator bundles were not 
being ordered. Within the first week, a follow-up spot 
check showed more MV patients with bundle orders.
For the period 2 intervention, we created several work-
groups to individually address various components of the 
order set; the workgroups later met together to address 
all operational elements in the order set, clarifying the 
responsibilities of each provider (eg, physician, nurse, 
RT) to ensure seamless transitions. A primary goal was 
reorganising the order set visually with prominent display 
of ‘mandatory’ guideline-based practices (ie, SATs and 
SBTs). Once the clinical informatics team began building 
revisions, the order set underwent many iterations with 
feedback from the quality improvement fellow, the 
medical ICU director and a clinical informatics specialist 
who was formerly an ICU nurse; all tested the order set 
on fictitious patients in the EMR before settling on a final 
product (online supplemental figures 1A-1E).
While updating SAT and SBT orders in the order set, 
we learnt there was no standardised approach to oper-
ationalise SATs and SBTs. Orders were delivered incon-
sistently; some were verbal, and others were electronic. 
In February 2017, bedside audits showed that for 7 of 15 
patients, SATs and SBTs were performed without corre-
sponding electronic orders. Our medical ICU director 
and RTs had approved an SBT protocol in 2013; some 
RTs were unaware of its existence, while others felt 
disempowered to use it because of frequently conflicting 
verbal physician orders, leading them to wait for explicit 
approval from attending physicians to initiate the SBT 
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protocol during morning rounds. In contrast, nurses had 
never established an SAT protocol. These inconsisten-
cies in order entry and actualisation along with differing 
physician practices introduced variation into the MV care 
process that could cause higher MV duration and thereby 
VAE incidence; standardising that process would be crit-
ical to achieving success with the ventilator bundle. Thus, 
the ICU nurse manager and two bedside nurses worked 
together to establish a step-by-step process that would fit 
into their workflow and facilitate SBTs, which require 
sedation to be held. They adapted a protocol from 
another hospital and condensed the pathway to two steps: 
check for SAT exclusion criteria (ie, seizures, drug with-
drawal, high risk for ventilator-related injury, fraction of 
inspired oxygen greater than 0.70, vasopressor dose equal 
to or greater than 10 µg/kg/min, and concurrent para-
lytic infusion) and hold the sedative at the appropriate 
time (either 6:00 or 8:00) based on its duration of effect. 
We simplified the SBT protocol to include only param-
eters RTs routinely assessed. Contraindications for SBTs 
included concurrent sedative, analgesic or paralytic infu-
sions; haemodynamic instability; oxygen saturation less 
than 92%; positive end-expiratory pressure greater than 5 
mm Hg; fraction of inspired oxygen greater than 0.40; pH 
less than 7.3; and minute ventilation greater than 15 L/
min. We added the new SAT and updated SBT protocols 
to the order set.
In mapping SAT and SBT flow, we felt the configuration 
of RT staffing at the time would impede successful deploy-
ment of the ventilator bundle and therefore facilitated 
around-the-clock RT staffing in the ICU. Because RTs 
had not been physically present in the ICU at all hours, 
physicians were adjusting ventilator settings, making 
streamlining of ventilator weaning more challenging. To 
transition to the new staffing model of around-the-clock 
in-unit coverage, GLA’s chief of staff negotiated the addi-
tion of contractual RT staff, although several full-time RTs 
ultimately volunteered for ICU shifts.
Thus, to our planned order set revision, we added corre-
sponding nurse-driven and RT-driven SAT and SBT proto-
cols and stationing RTs in the ICU for 24-hour coverage 
for our period 2 intervention. All components were ready 
for implementation in April 2017. Our primary imple-
mentation strategy for these changes was education, with 
all ICU staff receiving education on the revised order 
set and protocols from their respective leaders (ie, the 
medical and surgical ICU directors, ICU nurse educator 
and RT director) on our improvement team. We designed 
and distributed badge and pocket cards to illustrate and 
remind providers of the process changes (online supple-
mentary figures 2 and 3). The quality improvement fellow 
attended a resident orientation to demonstrate use of the 
order set; she also went to a nurse huddle to review the 
new SAT protocol.
resulTs
There was a shift of 14 data points above the central line 
in both p charts of SAT and SBT order entry that began in 
November 2016, corresponding with period 1 (figure 1). 
At baseline, SAT and SBT order entry (ie, percentage of 
eligible patients with orders) averaged 29.9% and 51.2%, 
respectively; after the shift in November 2016, they aver-
aged 67.9% and 77.7%, respectively. Improvement was 
sustained for both measures at the end of December 2017.
There were no special cause variation signals on the 
run chart of monthly MV duration, although the run 
chart over its entire period (May 2015 to December 2017) 
exhibits a general downward trend (figure 2). During the 
baseline period, the median monthly MV duration was 
6.5 days (range 4.1–15.1 days); during periods 1 and 2, it 
was 4.8 days (range 3.7–8.9 days) at the end of December 
2017. Similarly, on the XbarS chart of quarterly MV 
duration, which spans October 2013 to December 2017, 
there are no special cause signals corresponding with our 
interventions, but there is an 8-point downward shift that 
begins in the first quarter of 2016 (ie, October 2015 to 
December 2015) a year before our intervention began 
(online supplementary figure 4). There are several special 
cause signals suggesting decreased variation on the S 
portion of the XbarS chart corresponding with period 1.
From October 2016 to December 2017, there were six 
VAEs with no systemic issues found after chart review. 
There was a statistically non-significant decrease in VAE 
rate from 6.8 events per 1000 ventilator days (5.2 events 
per 100 ventilated patients) at baseline to 1.3 events 
per 1000 ventilator days (0.7 events per 100 ventilated 
patients) during period 2. There were no special cause 
signals on the t chart of calendar days between VAEs 
(online supplementary figure 5). During the baseline 
period, the time between VAEs averaged 31.4 days (range 
0 to 109 days); during periods 1 and 2, it averaged 73.4 
days (range 8 to 198 days) at the end of December 2017.
On the XmR chart of number of MV patients per 
month, there is one data point (June 2017) that is above 
the upper control limit; however, there are no other 
special cause signals (see online supplementary figure 
6). The number of MV patients per month averaged 16.2 
patients (range 6–27 patients) between May 2015 and 
December 2017. There were no special cause signals on 
the XmR chart of ICU case severity index (online supple-
mentary figure 7). There were special cause signals (data 
points below or above lower or upper control limits) on 
the p chart of ventilator utilisation ratio, but none were 
sustained or clearly attributable to our intervention 
(online supplementary figure 8).
Results based on classical parametric statistics are 
presented in table 1. Findings are overall similar to chart 
analysis, showing statistically significant increases in SAT 
and SBT order entry in periods 1 and 2 and a decrease in 
ventilator utilisation ratio in period 2, with the additional 
finding of a statistically significant difference in MV dura-
tion between baseline and period 2 (p=0.049).
Feedback on usability of the revised order set and proto-
cols was mixed. Most residents had such little firsthand 
experience with the previous order set that it was nearly 
impossible to compare with the new order set, but none 
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Figure 1 P chart of percentage of eligible patients with spontaneous awakening trial (SAT) and spontaneous breathing 
trial (SBT) orders. Data plotted in dark blue with shift following intervention (11–16) highlighted in red. Central line (mean) in 
light blue. Upper and lower control limits in grey (dashed). Start of period 1 at solid arrow. Start of period 2 at dashed arrow. 
Interrupted time-series analysis comparison of baseline with periods 1 and 2 significant at p=0.002 for SAT order entry and 
p=0.013 for SBT order entry (for coefficient indicating immediate effect of intervention).
Figure 2 Run chart of mechanical ventilation (MV) duration aggregated monthly. Data plotted in dark blue. Central line 
(median) in light blue. Goal line in green. Start of period 1 at solid arrow. Start of period 2 at dashed arrow. Interrupted time-
series analysis comparison of baseline with periods 1 and 2 non-significant (p=0.590 for coefficient indicating immediate effect 
of intervention; p=0.588 for coefficient indicating trend following intervention).
who used the new order set reported issues. Several nurses 
questioned why fentanyl was not included as a sedative in 
the SAT protocol and voiced safety concerns, particularly 
regarding management of patients who became agitated 
when sedation was held.
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Table 1 Summary of findings
Baseline
(May 2015 to
October 2016)
Period 1
(November 2016 to 
March 2017)
Period 2
(April 2017 to 
December 2017)
VAE rate* (per 1000 ventilator days) 6.8 4.3 1.3
VAE rate* (per 100 ventilated patients) 5.2 3.3 0.7
Primary outcomes
  Mean MV duration, days (SD)† 7.2 (10.5) 5.5 (6.7) 4.7 (4.5)
Balancing measures
  No of MV patients per month (SD)‡ 16 (3.6) 18 (5.8) 15 (7.4)
  ICU case severity index (SD)‡ 1.09 (0.35) 1.16 (0.17) 1.10 (0.24)
  Ventilator utilisation ratio§ 0.23 0.24 0.17
Process measures
  % Order for SAT¶ 30% 67% 68%
  % Order for SBT¶ 51% 73% 81%
*Negative binomial regression comparison of period 1 with baseline and period 2 with baseline non-significant (p=0.468 and p=0.105, 
respectively, for VAE rate per 1000 ventilator days; p=0.506 and 0.059, respectively, for VAE rate per 100 ventilated patients).
†ANOVA F-test of baseline, period 1 and period 2 significant (p=0.017), post-test pairwise comparison of period 2 with baseline significant 
(p=0.049).
‡ANOVA F-test of baseline, period 1 and period 2 non-significant (p=0.647 for MV patients; p=0.894 for ICU case severity index).
§Pearson χ2 test of baseline, period 1 and period 2 significant (p<0.001), post-test pairwise comparison of period 2 with baseline significant 
(p<0.001) and comparison of period 2 with period 1 significant (p<0.001).
¶Pearson χ2 test of baseline, period 1 and period 2 significant (p<0.001), post-test pairwise comparison of period 1 with baseline significant 
(p<0.001) and comparison of period 2 with baseline significant (p<0.001) (for SAT and SBT orders).
ICU, intensive care unit; MV, mechanical ventilation; SAT, spontaneous awakening trial; SBT, spontaneous breathing trial.
lessons and limiTaTions
In this ventilator bundle implementation project, we 
found sustained improvements in processes and favour-
able trends in outcomes. Increases in SAT and SBT order 
entry were associated with attending physicians reminding 
residents to order the ventilator bundle, implying the 
simple but substantial effect attending physicians have 
on resident behaviour; we believe streamlining the order 
set in period 2 helped sustain the initial improvement 
in period 1. Although we did not achieve our goal of 
decreasing average MV duration to less than 3 days, chart 
analysis exhibits a clear downward trend and a statistically 
significant decrease in MV duration using classical statis-
tics. Because of the infrequency of VAEs and downward 
trend in MV duration starting before our intervention, we 
cannot definitively attribute decreases in VAE incidence 
and MV duration to our intervention. However, these 
changes, coupled with the significant decrease in varia-
tion of MV duration associated with our intervention, 
suggest that standardising ventilator weaning conferred 
some reduction in MV duration.
One reason we considered for not reaching our goal 
was varied actualisation of SAT and SBT orders. Prelim-
inary bedside audits of processes downstream to order 
entry showed RTs consistently performed SBTs when 
indicated, but there were missed opportunities for 
SATs. There were far more opportunities for SBTs since 
all MV patients necessarily need them before extuba-
tion. The RT staffing change in March 2017 enabled 
the SBT protocol’s success; the heightened presence 
of RTs gave them more visibility to other ICU staff and 
confidence with the SBT protocol. The RT director 
also noted improvements in RT documentation and 
empowerment.
Conversely, transitioning from a physician-directed 
SAT strategy to a nurse-driven SAT protocol was chal-
lenging for cultural reasons and also because only half 
of MV patients had sedative infusion orders and there-
fore needed SATs. This affected the absolute number 
of patients eligible for SATs. Based on the size of our 
ICU (22 beds) and our average ventilator utilisation 
ratio (0.27), on a given day, we would expect to see six 
mechanically ventilated patients; furthermore, based 
on our sedative infusion use (50%), we would expect 
three of these six patients to be on continuous seda-
tion. Of these three patients, any number of them may 
have contraindications to the SAT protocol (eg, high 
oxygenation or vasopressor requirements) resulting in 
few if any patients eligible for an SAT, in absolute terms. 
In response to the audit findings showing missed SATs, 
our ICU nurse educator repeated in-service sessions 
for nurses to review and answer questions about the 
protocol. However, many nurses nonetheless voiced 
safety concerns about the protocol, which ultimately 
led to its not being accepted. These concerns may be 
difficult to dispel due to the infrequency of patients 
needing SATs.
Safety concerns about SAT protocols are not isolated 
to GLA. According to a national survey of ICU providers, 
37% of respondents ‘rarely’ or never use daily SATs, and 
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22% of respondents cite lack of nursing acceptance as a 
barrier.27 Common reasons for providers to hesitate in 
using SATs include fears of causing agitation or self-ex-
tubation. However, randomised trials have only shown 
slightly higher rates of agitation and self-extubation in 
MV patients undergoing SATs, with similar reintubation 
rates.23 28 Patients who received daily SATs had more 
ventilator-free days and shorter time to discharge from 
the ICU and hospital.28 Clearly, safety concerns endure 
despite evidence of the net benefit of SATs.
Other work has shown the benefit of empowering 
RTs and nurses to initiate SBTs and SATs, respectively. 
One randomised clinical trial assessing the impact of 
RT-led SBTs reduced the average MV duration from 6 
to 4.5 days, similar to our findings21; our interventions, 
particularly the RT staffing change and SBT protocol in 
period 2, likely helped contribute to this overall trend 
towards improvement. Another randomised clinical trial 
assessing the impact of nurse-led SATs reduced average 
MV duration from 4.9 to 2.3 days,23 but it is unclear 
whether additional effort is warranted to promote SATs 
in GLA’s ICU. Admitting diagnosis and degree of phys-
iological derangement have also been associated with 
MV duration,20 so with GLA’s high case severity index, 
our ability to further reduce MV duration may be small.
conclusions
The ability to reduce VAEs depends on the number 
of ventilated patients and their MV duration. If few 
patients are ventilated, and among those few, only 
some have risks that ventilator bundles address (eg, 
use of sedative infusions), there may be limited oppor-
tunity to decrease VAEs, and the ability to institution-
alise recommended practices (eg, SATs) may be more 
challenging. Ultimately, our improvement team imple-
mented process changes to increase usage of a venti-
lator bundle, which contributed to improvement in MV 
duration. Because we now face diminishing marginal 
returns with standard evidence-based practices, our 
next steps are to instil broader cultural changes among 
the ICU staff to increase accountability and teamwork, 
which will improve processes that affect VAEs and also 
other elements of care that affect outcomes for critically 
ill patients.
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